Check our Coronavirus page for answers to frequently asked questions on Epilepsy and COVID-19.
Coronavirus FAQsUpdate on 1 April 2020
Sanofi has told us they expect stock of 200mg Epilim gastro-resistant tablets will be back to normal levels from 10 April. There is good supply of other Epilim products.
Sanofi also says Depakote (valproic acid) gastro-resistant 250mg and 500mg tablets are out of stock, but will be back in stock from 10 April.
Epanutin (phenytoin) oral suspension is due to be out of stock from 2 March until June 2020.
Phenytoin sodium NRIM 100mg capsules made by Accord are out of stock in the UK.
The Department of Health and Social Care has told us there is a supply issue affecting all strengths of Convulex (valproic acid) capsules.
Martindale Pharma have told us that Tapclob clobazam 5 mgs oral suspension is out of stock due to a manufacturing problem.
All other preparations are in stock.
If you usually take Martindale Pharma Tapclob clobazam, your pharmacist may need to supply you with a different manufacturer’s version. If you have any concerns about this, speak to your GP, epilepsy specialist or epilepsy specialist nurse.
Update: 18 November 2019
All strengths of Gabitril tablets are back in stock.
Update: 24 October 2019
Teva has told us they expect to have Gabitril (tiagabine) 10mg tablets back in stock this week. Supplies should arrive at pharmacies in the week beginning 28 October 2019.
Teva hopes to have the 5mg and 15mg strength tablets back in stock in the week beginning 11 November.
If pharmacists are having trouble getting hold of Gabitril they can contact Teva customer services on 0800 590 502 for help.
Update 5 November 2019: Pfizer has been in touch to say Epanutin Infatabs are still out of stock and they are expecting a further manufacturing delay. Pfizer has ordered extra supplies of Dilantin Infatabs from Canada to cover the shortfall until mid-2020.
Update 3 May 2019: Pfizer now expects Epanutin Infatabs will be back in stock in November 2019.
Update - 16 October 2019
Teva topiramate tablets are out of stock in all strengths. Teva expects to have them back in stock in early 2020.
Teva has stopped making topiramate capsules.
If you usually take Teva topiramate, your pharmacist may need to supply you with a different manufacturer’s version. If you have any concerns about this, speak to your GP, epilepsy specialist or epilepsy specialist nurse.
Original story - 23 January 2019
Update on 10 October 2019 - Accord topiramate tablets
Accord topiramate tablets are now out of stock in the 25mg, 50mg and 100mg strengths. Accord does not know when they will be back in stock.
The 200mg tablets are in stock.
Original story - 3 April 2019
Accord topiramate tablets are out of stock in the 50mg and 100mg strengths. Accord does not know when they will be back in stock.
The 25mg and 200mg tablets are in stock.
We have checked with UCB, the makers of Keppra, and there is a supply problem with Keppra 500mg.
They are not available at the wholesalers, but pharmacists can order them directly from UCB. No other dosages and formulations of Keppra are affected.
